Zymeworks Inc.
ZYME
$27.49
-$0.63-2.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.59M | 2.41M | 2.52M | 27.61M | 48.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.59M | 2.41M | 2.52M | 27.61M | 48.73M |
| Cost of Revenue | 27.44M | 34.46M | 31.24M | 35.58M | 34.45M |
| Gross Profit | -22.85M | -32.05M | -28.72M | -7.96M | 14.28M |
| SG&A Expenses | 19.34M | 15.07M | 15.43M | 14.15M | 14.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.77M | 49.53M | 46.67M | 49.72M | 49.40M |
| Operating Income | -42.18M | -47.12M | -44.15M | -22.11M | -674.00K |
| Income Before Tax | -45.29M | -46.35M | -41.48M | -18.27M | 2.13M |
| Income Tax Expenses | -273.00K | -2.19M | -270.00K | 1.34M | -186.00K |
| Earnings from Continuing Operations | -45.02M | -44.16M | -41.21M | -19.60M | 2.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.02M | -44.16M | -41.21M | -19.60M | 2.32M |
| EBIT | -42.18M | -47.12M | -44.15M | -22.11M | -674.00K |
| EBITDA | -41.05M | -45.98M | -43.07M | -20.56M | 1.82M |
| EPS Basic | -0.62 | -0.59 | -0.55 | -0.26 | 0.03 |
| Normalized Basic EPS | -0.39 | -0.39 | -0.34 | -0.15 | 0.02 |
| EPS Diluted | -0.62 | -0.59 | -0.55 | -0.26 | 0.03 |
| Normalized Diluted EPS | -0.39 | -0.39 | -0.34 | -0.15 | 0.02 |
| Average Basic Shares Outstanding | 72.99M | 74.67M | 75.34M | 75.77M | 75.34M |
| Average Diluted Shares Outstanding | 72.99M | 74.69M | 75.34M | 75.78M | 77.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |